Why the CEO Sells 31,000 Shares Worth of AXT Stock
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
This article compares expense ratios for SP 500 ETFs and index funds inside a Roth IRA, highlighting how fees affect long-term growth.
28,234 articlesWhen a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
A decade of reinvested dividends can turn a modest $1,000 investment in Chevron into a much larger nest egg, even as ...
As June trading hits mid-month, investors eye three mega-cap cloud leaders for renewed growth and long-term backlog s...
Public rifts among celebrity families can complicate daily life and future planning. This piece examines how Pax Joli...
San Francisco-based Peregrine Technologies locked in a $250 million Series D as it readies its platform for the 2026 ...
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
NVIDIA and AMD sit at the center of AI, gaming, and data centers. This guide breaks down which is the better buy now ...
A boutique investor firm makes a bold healthcare bet by accumulating over 2 million Baxter International shares. The ...
A veteran financial journalist breaks down abacus global (abx) 2025 Q4 results, explains what the numbers mean for 20...